Back to BLTE
UBS Group AG BLTE Position History
Belite Bio, Inc • Healthcare
Quarters held
12
Latest value
$17K
Q3 2026
Peak value
$113.9M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $303K |
| Q3 2025 | $536K |
| Q4 2025 | $15.1M |
| Q4 2025 | $5.5M |
| Q4 2025 | $24K |
| Q1 2026 | $113.9M |
| Q1 2026 | $8.2M |
| Q1 2026 | $398K |
| Q2 2026 | $34.6M |
| Q2 2026 | $17K |
| Q3 2026 | $26.9M |
| Q3 2026 | $17K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $17K | 100 | — | — |
| Q3 2026 | $26.9M | 158.3K | — | — |
| Q2 2026 | $17K | 113 | — | — |
| Q2 2026 | $34.6M | 224.9K | — | — |
| Q1 2026 | $398K | 2.5K | — | — |
| Q1 2026 | $8.2M | 51.7K | — | — |
| Q1 2026 | $113.9M | 714.2K | — | — |
| Q4 2025 | $24K | 153 | — | — |
| Q4 2025 | $5.5M | 34.5K | — | — |
| Q4 2025 | $15.1M | 94.1K | — | — |
| Q3 2025 | $536K | 7.2K | — | — |
| Q3 2025 | $303K | 4.1K | — | — |